This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Bladder Cancer
  • /
  • Guidelines on Non-muscle-invasive Bladder Cancer (...
Guideline

Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1 and CIS)

Read time: 1 mins
Last updated:29th Feb 2020

This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC), TaT1 and carcinoma in situ (CIS). The information presented is limited to urothelial carcinoma, unless specified otherwise. The aim is to provide practical recommendations on the clinical management of NMIBC with a focus on clinical presentation and recommendations.

 

Read full guideline